about
Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study.Renoprotection: a matter of blood pressure reduction or agent-characteristics?SFlt-1 elevates blood pressure by augmenting endothelin-1-mediated vasoconstriction in mice.Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trialEffects of antiproteinuric intervention on elevated connective tissue growth factor (CTGF/CCN-2) plasma and urine levels in nondiabetic nephropathy.The blood pressure lowering potential of sulodexide--a systematic review and meta-analysisMagnetic Resonance Imaging-Derived Renal Oxygenation and Perfusion During Continuous, Steady-State Angiotensin-II Infusion in Healthy HumansBlood pressure-lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies.Statin and the risk of renal-related serious adverse events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and other placebo-controlled trials.Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis.Role of the vascular wall in sodium homeostasis and salt sensitivity.Effects of thiazide-type and thiazide-like diuretics on cardiovascular events and mortality: systematic review and meta-analysis.Use of a Single Baseline Versus Multi-Year 24-Hour Urine Collections for Estimation of Long-Term Sodium Intake and Associated Cardiovascular and Renal Risk.Arterial and Cellular Inflammation in Patients with CKD.Quantification of nonosmotic sodium storage capacity following acute hypertonic saline infusion in healthy individuals.Sodium Restriction in Patients With CKD: A Randomized Controlled Trial of Self-management Support.Acute kidney injury defined according to the 'Risk,' 'Injury,' 'Failure,' 'Loss,' and 'End-stage' (RIFLE) criteria after repair for a ruptured abdominal aortic aneurysm.Hemodynamic Measurements for the Selection of Patients With Renal Artery Stenosis: A Systematic Review.Diminished impact of ethnicity as a risk factor for chronic kidney disease in the current HIV treatment era.Cerebrovascular, cardiovascular and renal hypertensive disease after hypertensive disorders of pregnancy.Ethnic Disparities in CKD in the Netherlands: The Healthy Life in an Urban Setting (HELIUS) Study.Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.Perceived Barriers and Support Strategies for Reducing Sodium Intake in Patients with Chronic Kidney Disease: a Qualitative Study.The renoprotective effects of sulodexide.Effect of the urotensin receptor antagonist palosuran in hypertensive patients with type 2 diabetic nephropathy.Mortality and cardiovascular risk in patients with a history of malignant hypertension: a case-control study.Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.Individual titration for maximal blockade of the renin-angiotensin system in proteinuric patients: a feasible strategy?Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels.Relationship between educational and occupational levels, and Chronic Kidney Disease in a multi-ethnic sample- The HELIUS study.Microvascular Permeability after an Acute and Chronic Salt Load in Healthy Subjects: A Randomized Open-label Crossover Intervention Study.Elevated N-terminal pro-brain natriuretic peptide levels predict an enhanced anti-hypertensive and anti-proteinuric benefit of dietary sodium restriction and diuretics, but not angiotensin receptor blockade, in proteinuric renal patients.Renal sympathetic nerve activity after catheter-based renal denervation.Relationship of High-Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin.Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System Intervention.Long-term survival after acute kidney injury following ruptured abdominal aortic aneurysm repair.Reply to Moso et al.Microvascular glycocalyx dimension estimated by automated SDF imaging is not related to cardiovascular disease.High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study.Can sodium excretion from single fasting morning urine really be used for estimation of dietary sodium intake?
P50
Q34356666-67FE64A5-0C85-47C2-A877-338DFA72F3BDQ35017152-E6C5A56A-F3C0-42FF-B1C6-E2DB5BE93C01Q35121861-A6D49691-C00D-4F45-8ADD-D4469393AE42Q35819489-3E8F99A6-3616-4C7D-B8E6-C36CD00768CDQ35985704-8F2F7E7E-0707-4517-921C-264A94AF3C78Q36410118-0D8B5AF5-50EC-453F-878D-E2BCE844DDBBQ37090880-AF4AEEB6-D1D1-49C1-88DE-6709A25E6419Q37334943-CEDFC0EA-31F4-4221-A202-B9C6AD31FC74Q38209127-719CF1C7-A8E7-46BD-844F-15DC9A3BF342Q38245997-8A8134FE-6BDC-47A6-874B-6AD2B55E8D3DQ38258022-8DC3E4BA-15D7-47A6-B140-BB39D99E9456Q38367051-F930AEFE-97B8-4E13-921E-83B66EF0BC71Q38706117-E7ACD6DC-134C-463E-8366-D676DBE68001Q38801508-0C832799-9809-462A-89C7-2301F0C2CF39Q38993178-CA399A3A-BF42-4A98-86AB-70BB08563F6CQ39087586-234EFEFD-B42B-400B-BEFE-A00FE544DF3AQ39163988-A05726EB-ACCB-438D-9189-428F37C4DCE3Q39316306-7BD97804-CC22-4F97-9995-2C70F70EB99AQ39438346-77B40A78-FA30-4E1D-AFFC-034ED9611309Q40285278-DD80B55B-204A-4128-B327-33E70AE98240Q40310984-ACE33591-EF09-46B4-95BA-7709225B3EDAQ41932859-A0673B6C-FA15-4216-822B-E5225CBEFDC0Q42687292-70023E93-E0E6-4D68-BF2F-F742D8403649Q42932642-5B3CB4AA-59C3-4E7E-A1A1-C47050A912F5Q43128733-EBB0AFA5-9573-493B-B1BF-609C6F44F10BQ46038034-26C69B80-7D2F-43FC-8025-9E2EE32DE3CFQ46226259-55C924E4-C125-482F-949A-49A8784DB975Q46529781-35265EEE-6CF0-4C38-9056-8EA6EAEAD5B5Q47104109-EC1F235F-6EE3-4BE0-A8FC-2C6027A5E693Q47118912-4338908B-1D3E-4B30-92DF-069AB9896462Q47768920-928E79CC-D533-4D1B-AE78-3B5E9E90A72DQ48936898-97DC8823-9C91-4CEB-A718-61ECA7C6EC14Q49390948-C156B31B-1116-4060-9D0C-3AF6BD09A1BDQ49875790-FFC9E149-7EA3-424F-BE0F-0B9BDA5A7B27Q50095858-3238379E-B534-439D-8312-E8399A831575Q50128968-1A5CD58F-7AC6-42AB-8E85-2561763E1551Q50138647-727B2DA2-FDD5-41E9-ACA6-AF56B435D5A2Q50715593-AA4315D3-6BD2-49CE-8AED-445E45833CC9Q51111868-F68B95DF-0977-4A62-88AE-B0546E56B9A6Q51313143-2202B7AE-DBF3-4FF2-BD34-AD0BE9794779
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Liffert Vogt
@ast
Liffert Vogt
@en
Liffert Vogt
@es
Liffert Vogt
@nl
Liffert Vogt
@sl
type
label
Liffert Vogt
@ast
Liffert Vogt
@en
Liffert Vogt
@es
Liffert Vogt
@nl
Liffert Vogt
@sl
prefLabel
Liffert Vogt
@ast
Liffert Vogt
@en
Liffert Vogt
@es
Liffert Vogt
@nl
Liffert Vogt
@sl
P106
P31
P496
0000-0002-4585-7505